Indications and uses
• for relief of occasional sleeplessness when associated with minor aches and pains • helps you fall asleep and stay asleep
• for relief of occasional sleeplessness when associated with minor aches and pains • helps you fall asleep and stay asleep
• do not take more than directed • drink a full glass of water with each dose • adults and children 12 years and over: take 2 caplets at bedtime • do not take more than 2 caplets in 24 hours • if taken with food, this product may take longer to work
• read all warnings and directions before use. Keep outer carton. • each caplet contains: sodium 21 mg • store at 20-25°C (68-77°F) • avoid high humidity and excessive heat above 40°C (104°F)
Diphenhydramine hydrochloride 25 mg
Naproxen sodium 220 mg (naproxen 200 mg) (NSAID)*
*nonsteroidal anti-inflammatory drug
Nighttime sleep-aid
Pain reliever
Allergy alert: Naproxen sodium may cause a severe allergic reaction, especially in people allergic to aspirin. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
Stomach bleeding warning: This product contains an NSAID, which may cause severe stomach bleeding. The chance is higher if you:
Heart attack and stroke warning: NSAIDs, except aspirin, increase the risk of heart attack, heart failure, and stroke. These can be fatal. The risk is higher if you use more than directed or for longer than directed.
ask a health professional before use. It is especially important not to use naproxen sodium at 20 weeks or later in pregnancy unless definitely directed to do so by a doctor because it may cause problems in the unborn child or complications during delivery.
In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
croscarmellose sodium, FD&C blue #1 aluminum lake, FD&C blue #2 aluminum lake, magnesium stearate, microcrystalline cellulose, polyethylene glycol, polyvinyl alcohol, povidone, silicon dioxide, talc, titanium dioxide
1-888-423-0139
TopCare® health
COMPARE TO ALEVE® pm ACTIVE INGREDIENTS
All Night Pain Relief PM
NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE TABLETS, 220 mg / 25 mg
PAIN RELIEVER (NSAID) • NIGHTTIME SLEEP-AID
Sleep Aid Plus 12-Hour Pain Reliever
actual size
20 CAPLETS†
†CAPSULE-SHAPED TABLETS

| Class | Version | Type | Effective |
|---|---|---|---|
| DIPHENHYDRAMINE Pharmacologic Class Indexing | 3 | Indexing - Pharmacologic Class | 20180813 |
| NAPROXEN Pharmacologic Class Indexing | 2 | Indexing - Pharmacologic Class | 20191108 |
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| QR code link | QR Code | 264-88-all-night-pain-relief-pm.jpg |
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| fef6ad89-235f-4274-ba49-a8e53642473e | Product name | 2 | 20250225 |
| 0e2e0f88-b076-afe1-4bdd-32bca4375bec | Product name | 3 | 20250127 |
| 87fed3e6-8fba-48ef-96b0-3a7fb54b96ff | Product name | 3 | 20230306 |
| b5fdaaec-7251-4da6-9cb2-4e9e76939ec8 | Product name | 1 | 20200623 |
| e76dbbc1-775d-722c-08ff-ed45e8a80def | Product name | 3 | 20181002 |
| 3e48c9c4-918d-5d23-2f0b-d2398b06be54 | Product name | 1 | 20140508 |
| 6f4f4521-fd56-1ae6-888b-3b021bd75c7c | Product name | 1 | 20140508 |
| 865c72dd-0d94-daac-f728-ddd4ded2a79e | Product name | 1 | 20140508 |
| ce67e27d-1d21-5465-4409-b0662dd99d4d | Product name | 1 | 20140508 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 36800-264-27 | topcare all night pain relief pm | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 | |
| 36800-264-27 | topcare all night pain relief pm | 80 in 1 BOTTLE | TABLET, FILM COATED | 80 | 6 | |
| 36800-264-60 | topcare all night pain relief pm | 20 in 1 BOTTLE | TABLET, FILM COATED | 20 | 6 | |
| 36800-264-60 | topcare all night pain relief pm | 1 in 1 CARTON | TABLET, FILM COATED | 1 | 6 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 36800-264 | 36800-264-60, 36800-264-27 |
Every source-derived ingredient row is available through these pages.
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM | 25MG;220MG | TABLET / ORAL | 2019-05-10 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A208499-001 | NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE | 25MG;220MG | TABLET / ORAL | 2019-05-10 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| topcare all night pain relief pm | DIPHENHYDRAMINE HYDROCHLORIDE, NAPROXEN SODIUM | Topco Associates LLC | a20f193e-4e64-400a-b605-df08026cb80b | 2025-12-11 | Warnings | 36800-264-27 36800-264-60 36800-264 36800026427 36800026460 32352610-bdfc-40f5-8d85-daa6fc9f7ae4 a20f193e-4e64-400a-b605-df08026cb80b |
Adverse event summaries are temporarily unavailable. Other product information remains available.